Christoph Hiemke, PhD | Psychiatrist.com

Therapeutic Reference Range for Olanzapine

Systematic Review

Therapeutic Reference Range for Olanzapine

July 19, 2023

A therapeutic reference range of 20–40 ng/mL for oral and long-acting injectable olanzapine yields optimal treatment effects in schizophrenia spectrum disorders. Dose reduction is not needed above 40 ng/mL...

Katja Wesner, Christoph Hiemke, Niels Bergemann, et al

Consensus Statement

Consensus on Monitoring Blood Antipsychotic Levels

May 19, 2020

The quantification of antipsychotic levels in blood, or therapeutic drug monitoring (TDM), could aid clinicians in numerous challenging scenarios. Learn more about using TDM for dosing decisions in this...

Georgios Schoretsanitis, John M. Kane, Christoph U. Correll, et al

Original Research

Duloxetine Dosing Strategies and Smoking Status

September 4, 2018

Cigarette smoking is common among individuals depression, and smoking can affect the metabolism of antidepressant medications. Read this article to learn dosing strategies that physicians can employ when treating...

Marc Augustin, Georgios Schoretsanitis, Christoph Hiemke, et al

Original Research

Venlafaxine and O-Desmethylvenlafaxine Concentrations in Plasma and Cerebrospinal Fluid

August 19, 2014

Michael Paulzen, Sarah Groppe, Simone C. Tauber, et al